Cardiff Oncology, Inc. (CRDF) vs Citius Oncology, Inc. (CTOR)
A side-by-side comparison of Cardiff Oncology, Inc. and Citius Oncology, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CRDF
Cardiff Oncology, Inc.
$1.10HealthcareDelayed quote: Oct 6, 2026, 11:54 AM EDT
CTOR
Citius Oncology, Inc.
$0.90HealthcareDelayed quote: Oct 6, 2026, 11:54 AM EDT
Total return — CRDF vs CTOR
growth of $100 · dividends reinvested · last 2yCRDF -51.7% (-30.5%/yr)CTOR -92.4% (-72.4%/yr)CRDF compounded faster over this window
Log scale — wide-divergence pair
CRDF CTOR
CRDF vs CTOR: by the numbers
- •CRDF is the larger company ($85M vs $83M market cap).
- •Both run net losses; CTOR's is the smaller (-648.32% vs -7884.06% net margin).
Metrics side by side
Valuation
| Metric | CRDF | CTOR |
|---|---|---|
| Forward P/E | N/A | 8.98 |
| P/S ratio | 166.89 | 11.75 |
| P/B ratio | 3.20 | 2.07 |
Profitability
| Metric | CRDF | CTOR |
|---|---|---|
| Gross margin | 100.00% | 0.00% |
| Operating margin | -8256.32% | 0.00% |
| Net margin | -7884.06% | -648.32% |
| ROE | -150.95% | -114.06% |
| ROIC | -159.30% | -88.72% |
Growth (annualized)
| Metric | CRDF | CTOR |
|---|---|---|
| Revenue CAGR (5Y) | 5.15% | N/A |
| Total return CAGR (5Y) | -30.36% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.